Related Experiment Video
Updated: Mar 2, 2026

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.8K
Fatigue after a first attack of suspected multiple sclerosis.
Roos M van der Vuurst de Vries1, Jan Ja van den Dorpel1, Julia Y Mescheriakova1
1MS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Summary
Fatigue is common in clinically isolated syndrome (CIS) and persists over time. Fatigue levels increase after a multiple sclerosis (MS) diagnosis but then stabilize.
Area of Science:
- Neurology
- Clinical Research
- Patient Outcomes
Background:
- Fatigue affects over 75% of multiple sclerosis (MS) patients.
- Fatigue at clinically isolated syndrome (CIS) onset predicts future MS diagnosis.
- The long-term fatigue trajectory post-CIS is not well understood.
Purpose of the Study:
- To investigate the long-term course of fatigue in patients experiencing CIS.
- To determine if fatigue levels change after a clinically definite multiple sclerosis (CDMS) diagnosis.
Main Methods:
- Prospective follow-up of 235 CIS patients (aged 18-50).
- Annual assessments using Krupp's Fatigue Severity Scale (FSS) and Hospital Anxiety and Depression Scale (HADS).
- Longitudinal data analyzed using mixed-effects models; Expanded Disability Status Scale (EDSS) recorded post-CDMS.
Main Results:
- Baseline fatigue predicted CDMS diagnosis (HR: 2.6).
- Fatigue Severity Scale (FSS) scores remained consistent in monophasic CIS and CDMS patients during initial follow-up.
- FSS scores significantly increased by 0.86 units after CDMS diagnosis (p=0.01), then stabilized.
Conclusions:
- Fatigue is a persistent symptom following CIS, often increasing after the onset of clinically definite MS.
- Fatigue levels appear to stabilize after an initial rise post-diagnosis.
- Understanding fatigue progression is crucial for managing MS symptoms.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Muscle Recovery and Fatigue
4.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
4.5K
Fatigue
901
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
901
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Myocarditis II: Clinical Features and Diagnostic Tests
389
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
389
Disorders of the Skeletal Muscle
2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K

